Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Meperidine · Demerol

Small molecule · Agonist of mu-opioid receptor (OPRM1) · developed by Hospira

Approved FDA
1 Registered trials

What is Meperidine?

Meperidine, also known as pethidine, is a synthetic piperidine opioid that acts as an agonist at opioid receptors, producing analgesia and sedation. It is studied for pain relief in labour.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Demerol, Pethidine
Drug type
Small molecule
Targets
mu-opioid receptor (OPRM1)
Mechanism
Agonist of mu-opioid receptor (OPRM1)
Pathways
opioid receptor signaling, CNS depression, smooth muscle effects
Developer
Hospira, Inc.
In trials of
STOK
FDA status
Approved as Demerol, NDA021171 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Jul 20, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02179294 Phase 4 Pain Relief in Labour Completed STOK

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Pain Relief in Labour

Other drugs acting on OPRM1

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.